Non-alcoholic steatohepatitis

an overview including treatments with herbals as alternative therapeutics

Menaka Thounaojam, Ravirajsinh Navalsinh Jadeja, Ranjisinh Vijaysinh Devkar, Ayalur Vadathala Ramachandran

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Non-alcoholic steatohepatitis (NASH), an under- recognized hepatic ailment with increasing prevalence, is fast emerging as the dark horse of hepatic related morbidity and mortality. Though introduced as a hepatic condition as early as 1980, detailed exploration of its causes, underlying mechanisms and therapeutics has largely remained an ignored or neglected field. Only recently, the focus of attention has gravitated towards an understanding of NASH as a pathological manifestation of significance and a search for possible therapeutic interventions. Treatment schedules as of now involve life style management and usage of anti-diabetic or anti-obesity drugs and antioxidants. In the present review, we have focused on the available treatment schedules including herbal agents, plant extracts, polyherbal formulations and isolated phytocompounds. We present here a review of the available literature on pre-clinical and clinical evaluations of herbals including our recent findings on two plant extracts which can be used in mitigating NASH. This review attempts to provide a comprehensive account of NASH and the future of therapeutics and remediation by herbal principles, an aspect of the urgent need to target this important medical condition that contributes to many cases of silent morbidity and mortality.

Original languageEnglish (US)
Pages (from-to)119-136
Number of pages18
JournalJournal of Applied Biomedicine
Volume10
Issue number3
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

Fingerprint

Fatty Liver
Plant Extracts
plant extracts
therapeutics
liver
morbidity
Anti-Obesity Agents
remediation
Liver
Remediation
Appointments and Schedules
lifestyle
Morbidity
obesity
Therapeutics
Antioxidants
Mortality
antioxidants
drugs
Life Style

Keywords

  • herbal medicine
  • non-alcoholic steatohepatitis
  • phytocompounds
  • polyherbal formulation

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Non-alcoholic steatohepatitis : an overview including treatments with herbals as alternative therapeutics. / Thounaojam, Menaka; Navalsinh Jadeja, Ravirajsinh; Vijaysinh Devkar, Ranjisinh; Vadathala Ramachandran, Ayalur.

In: Journal of Applied Biomedicine, Vol. 10, No. 3, 01.01.2012, p. 119-136.

Research output: Contribution to journalReview article

Thounaojam, Menaka ; Navalsinh Jadeja, Ravirajsinh ; Vijaysinh Devkar, Ranjisinh ; Vadathala Ramachandran, Ayalur. / Non-alcoholic steatohepatitis : an overview including treatments with herbals as alternative therapeutics. In: Journal of Applied Biomedicine. 2012 ; Vol. 10, No. 3. pp. 119-136.
@article{4a7b3a399d9a4e96b48650a506ac9a64,
title = "Non-alcoholic steatohepatitis: an overview including treatments with herbals as alternative therapeutics",
abstract = "Non-alcoholic steatohepatitis (NASH), an under- recognized hepatic ailment with increasing prevalence, is fast emerging as the dark horse of hepatic related morbidity and mortality. Though introduced as a hepatic condition as early as 1980, detailed exploration of its causes, underlying mechanisms and therapeutics has largely remained an ignored or neglected field. Only recently, the focus of attention has gravitated towards an understanding of NASH as a pathological manifestation of significance and a search for possible therapeutic interventions. Treatment schedules as of now involve life style management and usage of anti-diabetic or anti-obesity drugs and antioxidants. In the present review, we have focused on the available treatment schedules including herbal agents, plant extracts, polyherbal formulations and isolated phytocompounds. We present here a review of the available literature on pre-clinical and clinical evaluations of herbals including our recent findings on two plant extracts which can be used in mitigating NASH. This review attempts to provide a comprehensive account of NASH and the future of therapeutics and remediation by herbal principles, an aspect of the urgent need to target this important medical condition that contributes to many cases of silent morbidity and mortality.",
keywords = "herbal medicine, non-alcoholic steatohepatitis, phytocompounds, polyherbal formulation",
author = "Menaka Thounaojam and {Navalsinh Jadeja}, Ravirajsinh and {Vijaysinh Devkar}, Ranjisinh and {Vadathala Ramachandran}, Ayalur",
year = "2012",
month = "1",
day = "1",
doi = "10.2478/v10136-012-0008-9",
language = "English (US)",
volume = "10",
pages = "119--136",
journal = "Journal of Applied Biomedicine",
issn = "1214-021X",
publisher = "University of South Bohemia",
number = "3",

}

TY - JOUR

T1 - Non-alcoholic steatohepatitis

T2 - an overview including treatments with herbals as alternative therapeutics

AU - Thounaojam, Menaka

AU - Navalsinh Jadeja, Ravirajsinh

AU - Vijaysinh Devkar, Ranjisinh

AU - Vadathala Ramachandran, Ayalur

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Non-alcoholic steatohepatitis (NASH), an under- recognized hepatic ailment with increasing prevalence, is fast emerging as the dark horse of hepatic related morbidity and mortality. Though introduced as a hepatic condition as early as 1980, detailed exploration of its causes, underlying mechanisms and therapeutics has largely remained an ignored or neglected field. Only recently, the focus of attention has gravitated towards an understanding of NASH as a pathological manifestation of significance and a search for possible therapeutic interventions. Treatment schedules as of now involve life style management and usage of anti-diabetic or anti-obesity drugs and antioxidants. In the present review, we have focused on the available treatment schedules including herbal agents, plant extracts, polyherbal formulations and isolated phytocompounds. We present here a review of the available literature on pre-clinical and clinical evaluations of herbals including our recent findings on two plant extracts which can be used in mitigating NASH. This review attempts to provide a comprehensive account of NASH and the future of therapeutics and remediation by herbal principles, an aspect of the urgent need to target this important medical condition that contributes to many cases of silent morbidity and mortality.

AB - Non-alcoholic steatohepatitis (NASH), an under- recognized hepatic ailment with increasing prevalence, is fast emerging as the dark horse of hepatic related morbidity and mortality. Though introduced as a hepatic condition as early as 1980, detailed exploration of its causes, underlying mechanisms and therapeutics has largely remained an ignored or neglected field. Only recently, the focus of attention has gravitated towards an understanding of NASH as a pathological manifestation of significance and a search for possible therapeutic interventions. Treatment schedules as of now involve life style management and usage of anti-diabetic or anti-obesity drugs and antioxidants. In the present review, we have focused on the available treatment schedules including herbal agents, plant extracts, polyherbal formulations and isolated phytocompounds. We present here a review of the available literature on pre-clinical and clinical evaluations of herbals including our recent findings on two plant extracts which can be used in mitigating NASH. This review attempts to provide a comprehensive account of NASH and the future of therapeutics and remediation by herbal principles, an aspect of the urgent need to target this important medical condition that contributes to many cases of silent morbidity and mortality.

KW - herbal medicine

KW - non-alcoholic steatohepatitis

KW - phytocompounds

KW - polyherbal formulation

UR - http://www.scopus.com/inward/record.url?scp=84870388034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870388034&partnerID=8YFLogxK

U2 - 10.2478/v10136-012-0008-9

DO - 10.2478/v10136-012-0008-9

M3 - Review article

VL - 10

SP - 119

EP - 136

JO - Journal of Applied Biomedicine

JF - Journal of Applied Biomedicine

SN - 1214-021X

IS - 3

ER -